The framework is ancient and shared. The difference is how it's wired.
Buried within human DNA lies an ancient inheritance shared with bears and bats — a genetic architecture that once allowed our distant ancestors to slow metabolism, endure scarcity, and recover without harm. Two studies published in Science have now mapped this dormant circuitry with new precision, revealing that the same regulatory switches governing hibernation in animals are largely preserved in us. For the millions living with Type 2 diabetes, whose bodies have lost the ability to move fluidly between fasting and feeding, this discovery opens a quiet but consequential door: the machinery for metabolic resilience may not be absent, only untuned.
- Type 2 diabetes is rising globally, and current treatments manage symptoms rather than restoring the body's lost ability to shift gracefully between metabolic states.
- Hibernating animals perform exactly what diabetic bodies cannot — a controlled, reversible suppression of metabolism and insulin signaling, with no lasting organ damage.
- Researchers identified not a single gene but a coordinated network of ancient regulatory switches, conserved across 100 million years of evolution and still present in human DNA.
- The challenge now is learning to safely dial those switches — nudging the body toward metabolic flexibility without triggering unintended consequences.
- If the code can be cracked, therapies may emerge that reverse insulin resistance, buffer against metabolic aging, and reduce the need for extreme dietary interventions.
Two studies published in Science have surfaced something quietly remarkable: the genetic programs that allow bears and bats to survive months of near-suspended metabolism — and then wake up unharmed — are largely intact in human DNA as well.
Hibernating animals accomplish what seems biologically paradoxical. Before dormancy, they deliberately induce insulin resistance and suppress their metabolism. Upon waking, they reverse these changes completely, with no lasting damage to organs or tissues. It is a controlled shutdown and restart. Type 2 diabetes, by contrast, is defined by the body's failure to do something similar — to move smoothly between fasting and fed states. Insulin signaling falters, energy balance breaks down, and tissues accumulate damage over time.
Christopher Gregg and his team did not find a single hibernation gene. Instead, they mapped a coordinated genetic program governed by regulatory DNA switches — cis-regulatory elements — that act like dimmers, turning genes on and off at precise moments during fasting and recovery. By comparing DNA across hibernating and non-hibernating mammals, and focusing on regions conserved for roughly 100 million years, they traced which regulatory shifts appeared in parallel across hibernating species and linked them to metabolic responses.
The conclusion is both simple and far-reaching: humans retain much of this ancient framework. The wiring is there. The question is whether scientists can learn to adjust it safely — not to induce hibernation, but to restore the metabolic flexibility that chronic disease erodes. Done well, such therapies could help reverse aspects of Type 2 diabetes, ease obesity-related conditions, and support healthier aging. The medicine of the future, Gregg suggests, may draw less from synthetic compounds than from biology that evolution has been quietly preserving all along.
Two studies published in Science magazine have uncovered something unexpected in human DNA: the genetic blueprints that allow bears, bats, and other hibernating animals to survive months of dramatically slowed metabolism—and then wake up unharmed—appear to be largely intact in us as well.
The research examined how hibernators manage a feat that seems impossible. Before entering hibernation, these animals deliberately suppress their metabolism and develop insulin resistance. Then, when they emerge and begin feeding again, they reverse those changes completely, suffering no lasting damage to their organs or tissues. It's a controlled shutdown and restart that our bodies, by contrast, struggle to execute.
This matters because Type 2 diabetes is fundamentally a problem of what researchers call metabolic inflexibility. The body loses its ability to shift smoothly between fasting and fed states. Insulin signaling goes haywire. Energy storage and use become unbalanced. Tissues accumulate damage over time. Hibernators, meanwhile, perform this metabolic dance without consequence—which is precisely what makes their genetic toolkit so intriguing to scientists.
Christopher Gregg, the senior author of the studies, and his team didn't find a single hibernation gene or organ. Instead, they identified a coordinated genetic program controlled by regulatory DNA switches called cis-regulatory elements. These switches act like dimmers on a light, turning genes on and off at precise moments during fasting and recovery. The researchers compared DNA from hibernating species—bears, bats, and others—against non-hibernating mammals, including humans. They focused on stretches of DNA that have remained virtually unchanged for roughly 100 million years, a sign that evolution has preserved them because they serve critical functions. Then they traced which regulatory regions had shifted in parallel across multiple hibernating species and connected those shifts to genes involved in metabolic responses to fasting and refeeding.
The finding is straightforward but profound: humans retain a substantial portion of this ancient genetic framework. We have the wiring. The question now is whether scientists can learn to adjust those switches safely.
If they can, the implications ripple outward. Future therapies might help the body transition more effectively between metabolic states, restore insulin sensitivity, reduce the damage caused by prolonged metabolic stress, or produce some of the protective effects of fasting without requiring extreme dieting. For patients, this could mean new ways to manage or even reverse aspects of Type 2 diabetes, obesity-related diseases, and age-related metabolic decline—conditions that place enormous burdens on individuals, families, and health systems worldwide.
Gregg emphasized that the goal is not to put people into hibernation. Rather, it's to harness the biology of safe metabolic shutdown and recovery to protect organs during periods of stress—whether from diabetes, obesity, aging, or even surgery—and to enhance the body's flexibility and resilience as we age. The framework for metabolic flexibility is ancient and shared across species. What differs is how it's wired and deployed. If researchers can crack that code, the medicine cabinet of the future might look very different from the one we have today.
Notable Quotes
The goal would not be to make people hibernate. It would be to harness the biology of safe metabolic shutdown and recovery to protect organs during stress.— Christopher Gregg, senior author of the studies
The Hearth Conversation Another angle on the story
So these studies found that humans have hibernation genes. Does that mean we could actually hibernate?
Not quite. We have the genetic switches that hibernators use, but they're not wired the same way. It's like having the same tools in your toolbox but arranging them differently. The question is whether we can learn to flip those switches intentionally.
And that would help with diabetes how?
Type 2 diabetes is about metabolic inflexibility—the body can't shift smoothly between burning food and burning stored energy. Hibernators do this perfectly. They slow down, develop insulin resistance, then wake up and reverse it all without damage. If we could teach our bodies to do that, we could protect ourselves from the metabolic chaos that drives diabetes.
But wouldn't that require changing our genes?
Not necessarily changing them—adjusting them. These regulatory switches control when genes turn on and off. If scientists figure out how to safely adjust those switches, you might be able to improve how your body handles insulin and energy without rewriting your DNA.
How long until this becomes a treatment?
That's the honest question. They've identified the framework. Now comes the hard part: understanding exactly how to manipulate it safely in humans. It's not science fiction, but it's also not next year's medication.
What happens if it works?
You could potentially reverse aspects of diabetes, improve how your body ages, protect organs during surgery or illness, and do it all without extreme dieting or constant medication adjustments. It would be medicine based on biology we've carried with us for 100 million years.